Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Sarin

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Vaccine|September 6, 2001
Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chainD H Zimmerman, J P Lloyd, D Heisey, et al.
Science (New York, N.Y.)|February 18, 1983
Isolation and transmission of human retrovirus (human t-cell leukemia virus)M Popovic, P S Sarin, M Robert-Gurroff, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteinsJ M Steim, C Camaioni Neto, P S Sarin, et al.
Haematology and Blood Transfusion|January 1, 1983
Transmission of human T-cell leukemia virus (HTLV) into human cord blood T cellsP S Sarin, M Popovic, S Z Salahuddin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Biochemical Pharmacology|November 15, 1986
Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell cultureC P Schaffner, O J Plescia, D Pontani, et al.
The Journal of Clinical Investigation|August 1, 1986
Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytesD A Fetchick, D R Bertolini, P S Sarin, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|November 1, 1990
Differential in vitro anti-HIV activity of natural lignansH C Schröder, H Merz, R Steffen, et al.
Immunology Letters|February 1, 1989
Inverse relationship between HIV-1 p24 antigenemia, anti-p24 antibody and neutralizing antibody response in all stages of HIV-1 infectionY Sei, P H Tsang, F N Chu, et al.
Lancet (London, England)|August 31, 1985
Detection of infectious HTLV-III/LAV virus in cell-free plasma from AIDS patientsD Zagury, M Fouchard, J C Vol, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Vaccine|September 6, 2001
Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chainD H Zimmerman, J P Lloyd, D Heisey, et al.
Science (New York, N.Y.)|February 18, 1983
Isolation and transmission of human retrovirus (human t-cell leukemia virus)M Popovic, P S Sarin, M Robert-Gurroff, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteinsJ M Steim, C Camaioni Neto, P S Sarin, et al.
Haematology and Blood Transfusion|January 1, 1983
Transmission of human T-cell leukemia virus (HTLV) into human cord blood T cellsP S Sarin, M Popovic, S Z Salahuddin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.
Biochemical Pharmacology|November 15, 1986
Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell cultureC P Schaffner, O J Plescia, D Pontani, et al.
The Journal of Clinical Investigation|August 1, 1986
Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytesD A Fetchick, D R Bertolini, P S Sarin, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|November 1, 1990
Differential in vitro anti-HIV activity of natural lignansH C Schröder, H Merz, R Steffen, et al.
Immunology Letters|February 1, 1989
Inverse relationship between HIV-1 p24 antigenemia, anti-p24 antibody and neutralizing antibody response in all stages of HIV-1 infectionY Sei, P H Tsang, F N Chu, et al.
Lancet (London, England)|August 31, 1985
Detection of infectious HTLV-III/LAV virus in cell-free plasma from AIDS patientsD Zagury, M Fouchard, J C Vol, et al.
Pageof 12